Clinical Trials
Showing 1166 Clinical Trials-
Intranasal Ketamine for Procedural Sedation
Start Date: October 2022 Updated: August 2017
Ketamine
Phase 3
Unknown status
-
Start Date: October 2022 Updated: April 2021
Edmonton, Alberta, CanadaKetamine
Phase 4
Completed
-
The Effect of Sodium Oxybate on Sleep Architecture
Start Date: October 2022 Updated: February 2018
Boston, Massachusetts, USAGHB
Phase 2
Withdrawn
-
Trial of Xyrem (Sodium Oxybate) for the Treatment of Narcolepsy
Start Date: October 2022 Updated: November 2013
Toronto, Ontario, CanadaGHB
Phase 3
Completed
-
Pragmatic Trial of Psilocybin Therapy in Palliative Care
Start Date: October 2022 Updated: June 2022
Psilocybin
Phase 2
Not yet recruiting
-
Psilocybin-assisted Therapy for Treatment of Alcohol Use Disorder
Start Date: October 2022 Updated: June 2022
Psilocybin
Phase 2
Not yet recruiting
-
Start Date: September 2022 Updated: March 2021
Boston, Massachusetts, USAGHB
Early Phase 1
Withdrawn
-
Start Date: September 2022 Updated: April 2020
Oakland, California, USAKetamine
Phase 4
Completed
-
Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
Start Date: September 2022 Updated: February 2022
Kingston, JamaicaPsilocybin
Phase 2
Not yet recruiting
-
Ketamine for Depression and Suicide Risk
Start Date: September 2022 Updated: August 2017
Rochester, Minnesota, USAKetamine
Phase 2
Completed